Deal will Provide Cephalon New Path Forward for Development of its Tumor Necrosis Factor Inhibitor FRAZER, Pa. and WELLESLEY, Mass., Oct. 26 (HSMN NewsFeed) — Cephalon, Inc. (Nasdaq: CEPH ) and BioAssets Development Corporation (BDC), a privately hel…
Biopharmaceuticals, Mergers & Acquisitions
Cephalon, BioAssets Development Corporation, etanercept

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation”
Leave a Comment